Explore TAIGenomics
TAIGenomics offers an AI-driven omics data platform that enables healthcare providers and medical researchers to find the next clinical action plan. Our solutions can seamlessly analyze and interpret the experiment or clinical data across different disease areas, including heredity common disease risk, rare disease, and oncology. Partnering with TAIGenomics now to achieve your blueprint about the future of precision medicine.
Efficient omics bioinformatics tool set up & validation
Connecting data and information with AI
Flexible analytics architecture
Accumulate and Validate your omics data quality with trusted international guidelines.
Perform a patient’s absolute risk of common chronic disease.
Taiwan AI Lab partners with Shin Kong Hospital on realizing personalized medicine with QCheck system
2022/3/17
Taiwan AI Labs Partners With Shin-Kong Hospital for Ensuring Quality in Clinical Application of NGS
2022/3/17
Taiwan AI Labs partners with National Taiwan University build DockCov2 for COVID-19 soultion discovery
2020/11/1
Taiwan AI Labs Apply Drug Repurposing in Anti-Covid19 Database
2020/10/21
AI platform for automatic identification of malaria in CDC-funded challenge
2018/12/3
pubmedKB: an interactive web server for exploring biomedical entity relations in the biomedical literature
Nucleic Acids Research
IF 16.971
2022.5.10
Efficiently predicting vancomycin resistance of Enterococcus faecium from MALDI-TOF MS spectra using a deep learning-based approach.
Frontiers in Microbiology
IF 5.64
2022.4.28 accepted
ezGeno: An Automatic Model Selection Package for Genomic Data Analysis
Bioinformatics
IF 6.937
2022.1.1
Connecting MHC-I-binding motifs with HLA alleles via deep learning
Communcations Biology
IF 6.268
2021.10.18
DockCoV2: a drug database against SARS-CoV-2
Nucleic Acids Research
IF 16.971